AcaHealth Pharma & Biotech Co.,LTD

長安醫藥生技 Innovative R&D

About

  

 
Event hub will open on June 9, presentations will be available until July 18 to all registered attendees
 

 

Unique in human experienced anti-aging herb

derived drug discovery:

Aim for aging related unmet medical need

 

AcaHealth Pharma & Biotech Company was founded by Professor & Director Rong-Tsun Wu in2009, originated from Research Center fot Drug Discovery, National Yang-Ming University. Our comany focus on:

1. Pure chemical drug discovery development.

AcaHealth company focus on human experienced medicine-based drug discovery & development, aiming for unmet medical need especially aging related diseases such as chronic heart failure, chronic kidney disease, dry eye, neurodegenerative diseases, macular degeneration or insomnia.
US FDA approved AH-101-CVD for clinical trial(Chronic Heart Failure) in 2020 Jan.

Taiwan FDA approved AH-101-CVD for clinical trial(Chronic Heart Failure) in 2020 Oct.

We are on-going phase 1 clinical trial in Taipei Medical University Hospitals in 2021 July.

2. Botanical drug discovery & development.

3. High technology platform for producing active ingredients by plant tissue culture.

Copyright © 2020 長安醫藥生技 AcaHealth Pharma & Biotech Company

WebMake SiteBuild | HiYP B2B Service | TaiwanDNS